137 related articles for article (PubMed ID: 12713987)
1. Transduction of adenovirus-mediated wild-type p53 after radiotherapy in human cervical cancer cells.
Huh JJ; Wolf JK; Fightmaster DL; Lotan R; Follen M
Gynecol Oncol; 2003 May; 89(2):243-50. PubMed ID: 12713987
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status.
Wolf JK; Mills GB; Bazzet L; Bast RC; Roth JA; Gershenson DM
Gynecol Oncol; 1999 Nov; 75(2):261-6. PubMed ID: 10525383
[TBL] [Abstract][Full Text] [Related]
3. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro.
Hamada K; Zhang WW; Alemany R; Wolf J; Roth JA; Mitchell MF
Gynecol Oncol; 1996 Mar; 60(3):373-9. PubMed ID: 8774641
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
7. Combined radiation and p53 gene therapy of malignant glioma cells.
Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of an adenovirus expressing p73 beta, a p53 homologue, against human papilloma virus positive cervical cancer in vitro and in vivo.
Das S; Somasundaram K
Cancer Biol Ther; 2006 Feb; 5(2):210-7. PubMed ID: 16481734
[TBL] [Abstract][Full Text] [Related]
10. pRb-expressing adenovirus Ad5-Rb attenuates the p53-induced apoptosis in cervical cancer cell lines.
Ip SM; Huang TG; Yeung WS; Ngan HY
Eur J Cancer; 2001 Dec; 37(18):2475-83. PubMed ID: 11720846
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
Ramondetta L; Mills GB; Burke TW; Wolf JK
Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppression and therapy sensitization of localized and metastatic breast cancer by adenovirus p53.
Lebedeva S; Bagdasarova S; Tyler T; Mu X; Wilson DR; Gjerset RA
Hum Gene Ther; 2001 May; 12(7):763-72. PubMed ID: 11339893
[TBL] [Abstract][Full Text] [Related]
13. Distinctive cell cycle regulatory protein profiles by adenovirus delivery of p53 in human papillomavirus-associated cancer cells.
Jin HS; Bae SM; Kim YW; Lee JM; Namkoong SE; Han BD; Lee YJ; Kim CK; Chun HJ; Ahn WS
Int J Gynecol Cancer; 2006; 16(2):698-707. PubMed ID: 16681750
[TBL] [Abstract][Full Text] [Related]
14. Differential suppression of human cervical cancer cell growth by adenovirus delivery of p53 in vitro: arrest phase of cell cycle is dependent on cell line.
Ahn WS; Han YJ; Bae SM; Kim TH; Rho MS; Lee JM; Namkoong SE; Park YS; Kim CK; Sin JI
Jpn J Cancer Res; 2002 Sep; 93(9):1012-9. PubMed ID: 12359055
[TBL] [Abstract][Full Text] [Related]
15. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on adenovirus-mediated transfer of p53 or adenovirus- mediated transfer of p53 combined with radiotherapy for human cervical cancer cell line HeLa cells].
Kong W; Sun J; Lin C; Zha Y; Lu G; Fu M; Zhang X
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):352-5. PubMed ID: 12126571
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulatory protein expression profiles by adenovirus p53 infection in human papilloma virus-associated cervical cancer cells.
Lee YS; Bae SM; Kwak SY; Park DC; Kim YW; Hur SY; Park EK; Han BD; Lee YJ; Kim CK; Kim DK; Ahn WS
Cancer Res Treat; 2006; 38(3):168-77. PubMed ID: 19771278
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation.
Colletier PJ; Ashoori F; Cowen D; Meyn RE; Tofilon P; Meistrich ME; Pollack A
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1507-12. PubMed ID: 11121656
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated p14ARF gene transfer cooperates with Ad5CMV-p53 to induce apoptosis in human cancer cells.
Tango Y; Fujiwara T; Itoshima T; Takata Y; Katsuda K; Uno F; Ohtani S; Tani T; Roth JA; Tanaka N
Hum Gene Ther; 2002 Jul; 13(11):1373-82. PubMed ID: 12162819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
